Despite this, there are still reservations about the move’s viability. There have been calls for the changeover to be delayed. The claim is that the numerous difficulties involved would make it difficult to put the order into action.
Source: The Economic Times
If the inquiries are seen as constructive criticism rather than a malicious retaliation, the healthcare system’s restructuring will benefit more from it. Address them through a comprehensive consultation process and, possibly, proceed in stages.
One cannot stress the value of marketing generic medications. The ambiguity surrounding the quality parameters is the main worry. Trust issues with patients, accessibility issues, regulatory clarity issues, and industry influence issues have been brought forward.
The leading organization of medical professionals has referred to the instruction as running trains without tracks. It has argued against sacrificing patient care in order to save money. It has been noted that it is contradictory to permit the licensing of branded medications while forbidding physicians from prescribing them.
Source: CNBC- TV 18
Doctors are prohibited from attending meetings sponsored by pharmaceutical corporations under the NMC’s new professional conduct rules. Additionally, neither they nor members of their families may accept honoraria or consulting payments. Doctors are not permitted to promote or advertise medicine companies or medical equipment.
Any effort to stop unethical behavior is appreciated. Without a strong regulatory framework, there will always be doubts about whether these standards will be adhered to in text and spirit. The action to prevent violence towards doctors is noteworthy. They can refuse care to violent and abusive patients or families, but they must take care to make sure no patient is left behind.
What do you think about this? Comment below.
